Inventor · disambiguated record
John Charles Tomesch
Also filed as: TOMESCH JOHN · TOMESCH JOHN C · TOMESCH JOHN CHARLES
24 granted patents·1 pending application·1,078 citations·filing 1981–2024
97Inventor score
Files withINTRA CELLULAR THERAPIES INC13TOMESCH JOHN3PENG YOUYI2SANDOZ PHARMACEUTICALS CORP2TOMESCH JOHN CHARLES2
Top patents by PatentIndex Score
25 records- 0199US11407751B2Hydrochloric acid salt of (6bR,10aS)-3-methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalineINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Aug 9, 2022·19 cites·1 claims
- 0299US9371324B2Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disordersINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Jun 21, 2016·90 cites·26 claims
- 0398US10464938B2Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Nov 5, 2019·33 cites·12 claims
- 0498US9751883B2Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2016·Granted Sep 5, 2017·86 cites·28 claims
- 0598US9586960B24-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de] quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid salt crystal formsTOMESCH JOHN·Filed 2015·Granted Mar 7, 2017·90 cites·2 claims
- 0698US9315504B2Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereofINTRA CELLULAR THERAPIES INC·Filed 2014·Granted Apr 19, 2016·88 cites·5 claims
- 0798US9199995B24-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystalsTOMESCH JOHN·Filed 2014·Granted Dec 1, 2015·94 cites·14 claims
- 0898US8648077B24-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystalsTOMESCH JOHN·Filed 2009·Granted Feb 11, 2014·133 cites·27 claims
- 0997USRE48825E4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid salt crystal formsINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Nov 23, 2021·13 cites·23 claims
- 1097US11066407B2Preparation of certain substituted 1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Jul 20, 2021·14 cites·10 claims
- 1197US10597395B2Preparation of certain substituted 1-(4-fluorophenyl)-4-(2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-YL)butan-1-ones and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Mar 24, 2020·23 cites·19 claims
- 1297US10221176B2Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2017·Granted Mar 5, 2019·28 cites·29 claims
- 1397US8993572B2Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivativesMATES SHARON·Filed 2011·Granted Mar 31, 2015·112 cites·19 claims
- 1497US8779139B2Substituted 2,3,4,4A,5,9B-hexahydro-1H-pyrido[4,3-B]indole derivatives synthesis and uses thereofTOMESCH JOHN CHARLES·Filed 2012·Granted Jul 15, 2014·108 cites·15 claims
- 1597US8309722B2Substituted heterocycle gamma-carbolines synthesisTOMESCH JOHN CHARLES·Filed 2008·Granted Nov 13, 2012·117 cites·44 claims
- 1691US2025101022A1PROCESS FOR PREPARING INTERMEDIATES FOR 1-(4-FLUOROPHENYL)-4-((6bR,10aS)-3-METHYL-2,3,6b,9,10,10a-HEXAHYDRO-1H-PYRIDO[3’,4’:4,5]PYRROLO[1,2,3-de]QUINOXALIN-8(7H)-YL)BUTAN-1-ONEINTRA CELLULAR THERAPIES INC·Filed 2024·Application pending·0 cites
- 1783US12139490B2Process for preparing 1-(4-fluorophenyl)-4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-oneINTRA CELLULAR THERAPIES INC·Filed 2022·Granted Nov 12, 2024·0 cites·18 claims
- 1881US9708294B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2016·Granted Jul 18, 2017·2 cites·2 claims
- 1979US9108949B2Compounds and methods of prophylaxis and treatment regarding nicotinic receptor antagonistsPENG YOUYI·Filed 2012·Granted Aug 18, 2015·4 cites·16 claims
- 2077US9469625B2Organic compoundsLI PENG·Filed 2012·Granted Oct 18, 2016·2 cites·34 claims
- 2177US4366154ATropyl derivativesSANDOZ AG·Filed 1981·Granted Dec 28, 1982·11 cites·19 claims
- 2272US4820718AN-alkyl-(2- or 5-substituted-2-methoxycarbonyl aminoalkyl furanyl)-substituted cyclimmonium salts and use thereof in PAF inhibitionSANDOZ PHARMACEUTICALS CORP·Filed 1987·Granted Apr 11, 1989·9 cites·21 claims
- 2352US9452160B2Compounds and methods of prophylaxis and treatment regarding nicotinic receptor antagonistsPENG YOUYI·Filed 2015·Granted Sep 27, 2016·0 cites·10 claims
- 2443US4868319AProcess for the preparation of monoalkylcarbamate group-containing compoundsSANDOZ PHARMACEUTICALS CORP·Filed 1987·Granted Sep 19, 1989·2 cites·52 claims
- 2539US9944648B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Apr 17, 2018·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when John Charles Tomesch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →